Solid Biosciences (SLDB) Prepaid Assets (2017 - 2026)
Quarterly results put Prepaid Assets at $15.5 million for Q1 2026, up 138.33% from a year ago — trailing twelve months through Mar 2026 was $15.5 million (up 138.33% YoY), and the annual figure for FY2025 was $16.4 million, up 95.47%.
Solid Biosciences has reported Prepaid Assets over the past 10 years, most recently at $15.5 million for Q1 2026.
- Prepaid Assets reached $15.5 million in Q1 2026 per SLDB's latest filing, down from $16.4 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $18.5 million in Q1 2022 and bottomed at $5.1 million in Q1 2023.
- Median Prepaid Assets over the past 5 years was $7.3 million (2024), compared with a mean of $8.9 million.
- The largest annual shift saw Prepaid Assets skyrocketed 236.06% in 2022 before it tumbled 72.52% in 2023.
- Over 5 years, Prepaid Assets stood at $5.9 million in 2022, then increased by 3.01% to $6.1 million in 2023, then skyrocketed by 37.55% to $8.4 million in 2024, then soared by 95.47% to $16.4 million in 2025, then dropped by 5.58% to $15.5 million in 2026.
- Business Quant data shows Prepaid Assets for SLDB at $15.5 million in Q1 2026, $16.4 million in Q4 2025, and $8.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.47 Mn |
| Dec 31, 2025 | 16.38 Mn |
| Sep 30, 2025 | 8.71 Mn |
| Jun 30, 2025 | 10.53 Mn |
| Mar 31, 2025 | 6.49 Mn |
| Dec 31, 2024 | 8.38 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 7.34 Mn |
| Mar 31, 2024 | 8.13 Mn |
| Dec 31, 2023 | 6.09 Mn |
| Sep 30, 2023 | 5.46 Mn |
| Jun 30, 2023 | 7.28 Mn |
| Mar 31, 2023 | 5.10 Mn |
| Dec 31, 2022 | 5.92 Mn |
| Sep 30, 2022 | 5.12 Mn |
| Jun 30, 2022 | 7.32 Mn |
| Mar 31, 2022 | 18.54 Mn |
| Dec 31, 2021 | 14.72 Mn |
| Sep 30, 2021 | 8.37 Mn |
| Jun 30, 2021 | 5.74 Mn |
| Mar 31, 2021 | 5.52 Mn |
| Dec 31, 2020 | 4.16 Mn |
| Sep 30, 2020 | 2.37 Mn |
| Jun 30, 2020 | 3.09 Mn |
| Mar 31, 2020 | 4.32 Mn |
| Dec 31, 2019 | 2.78 Mn |
| Sep 30, 2019 | 7.83 Mn |
| Jun 30, 2019 | 10.94 Mn |
| Mar 31, 2019 | 7.04 Mn |
| Dec 31, 2018 | 6.18 Mn |
| Sep 30, 2018 | 3.06 Mn |
| Jun 30, 2018 | 1.71 Mn |
| Mar 31, 2018 | 1.93 Mn |
| Dec 31, 2017 | 1.50 Mn |